Dexcom, Inc. acquires AMSL and NZMS
August 2021
Richard Plowright, Managing Director and Owner of Australasian Medical & Scientific Limited (AMSL) and New Zealand Medical & Scientific (NZMS) has announced his retirement, after over 30 years of providing the Australasian market with access to leading edge healthcare solutions from all over the world. As of the 1st August 2021, Richard has sold all his shares in both companies to Dexcom, Inc., a leader in the medical technology industry and as such, Dexcom, Inc. has now acquired AMSL and NZMS.
Dexcom, Inc., AMSL and NZMS will continue to provide high quality products and services across the Allergy, Diabetes, Medical, Point of Care/Diagnostics, Regenerative Medicine and Scientific divisions. We are driven by our vision to create positive healthcare outcomes for our customers by providing innovative technologies, supported by our team’s expertise, professionalism, and commitment. This acquisition of AMSL and NZMS further strengthens Dexcom’s position as a leading provider of medical technology. At the heart of this acquisition is a mission to form an even greater business together; to expand our footprint in the healthcare industry, to grow the careers of employees, and to change more lives. Our suppliers and customers will experience no difference in our day-to-day activities with all staff to be retained.
About Dexcom, Inc.
Dexcom, Inc. was founded in 1999 with the mission to empower people to take control of diabetes through innovative Continuous Glucose Monitoring (CGM) systems. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Headquartered in San Diego, California, with additional offices in the U.S., Europe, and Asia Pacific, Dexcom employs more than 5,000 people worldwide. For more information on Dexcom, Inc. visit Dexcom.com.
For more information:
If you have any questions or feedback regarding this announcement, please contact our Customer Service Team, your local AMSL Territory Manager or alternatively contact AMSL Diabetes diabetes@amsl.com.au or calling 1300 851 056.
